PAYS (PAYS) revenue breakdown
By product, Plasma Industry is the largest at 56% of fiscal 2025 revenue; Pharma Industry grew fastest, 91% a year over 7 years.
Revenue by product
Fiscal years, as PAYS reports them in its 10-K filings; fiscal 2025 total $82M.
| Products | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|
| Plasma Industry | $23M | $27M | $23M | $26M | $35M | $42M | $44M | $46M | 56% |
| Pharma Industry | $366,442 | $7M | $326,699 | $3M | $3M | $4M | $13M | $34M | 41% |
| Other Revenue | $25,410 | $298,734 | $392,667 | $184,830 | $288,887 | $1M | $2M | $3M | 3% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for PAYS.
Open PAYS in InvestinglyQuestions
Where does PAYS make its money?
In fiscal 2025, by product: Plasma Industry $46M, Pharma Industry $34M, Other Revenue $3M.
From PAYS's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.